Biotech · Private company
Mitotech, SA
Track this companyFree. Adds Mitotech, SA to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- High dose - SkQ1Phase 3 · Dry Eye SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Low Dose - SkQ1Phase 3 · Dry Eye SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- SkQ1 (Vehicle)Phase 3 · Dry Eye SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- SkQ1 Ophthalmic SolutionPhase 3 · Dry Eye SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- SkQ1 Vehicle SolutionPhase 3 · Dry Eye SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- High Dose 1.55µg/mL SkQ1 ophthalmic solutionPhase 2 · Keratoconjunctivitis SiccaClinicalTrials.gov · fetched Nov 12, 2026
- Low Dose 0.155µg/mL SkQ1 ophthalmic solutionPhase 2 · Keratoconjunctivitis SiccaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Vehicle-Controlled Study of SkQ1 as Treatment for Dry-eye SyndromePHASE3 · COMPLETED · started Dec 20, 2019ClinicalTrials.gov NCT04206020 · fetched Nov 12, 2026
- Study of SkQ1 as Treatment for Dry-eye SyndromePHASE3 · COMPLETED · started Dec 6, 2018ClinicalTrials.gov NCT03764735 · fetched Nov 12, 2026
- A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)PHASE2 · COMPLETED · started Apr 1, 2014ClinicalTrials.gov NCT02121301 · fetched Nov 12, 2026